Compare
FRno tier1 verifiedremove
Keensight Capital is a European Growth Buyout investor with expertise in Technology and Healthcare, partnering with management teams of growing companies to provide capital, guidance, and support. The company has over 25 years of experience and manages assets worth over 8 billion euros.
Claims
- Science Based Targets initiativeverified · expires 2027-08-15
FRno tier1 verifiedremove
Kephren is a team of experts with diverse and complementary expertise in the field of oncology and hematology, offering a range of services including strategic consulting and project management. The company provides a personalized and comprehensive approach to supporting clients in the life cycle management of their molecules and medical devices.
Claims
- Science Based Targets initiativeverified · expires 2027-08-15